Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1994 1
1995 5
1996 1
1997 2
1999 5
2001 4
2002 2
2003 5
2004 1
2005 2
2006 5
2007 8
2008 7
2009 12
2010 11
2011 10
2012 13
2013 21
2014 15
2015 24
2016 32
2017 41
2018 23
2019 23
2020 36
2021 25
2022 22
2023 16
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25022442

301 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain.
Alonso A, González CM, Ballina J, García Vivar ML, Gómez-Reino JJ, Marenco JL, Fernández-Nebro A, Ordás C, Cea-Calvo L, Arteaga MJ, Sanmartí R. Alonso A, et al. Reumatol Clin. 2015 May-Jun;11(3):144-50. doi: 10.1016/j.reuma.2014.05.002. Epub 2014 Jul 10. Reumatol Clin. 2015. PMID: 25022442 Free article. Clinical Trial.
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.
Combe B, Dasgupta B, Louw I, Pal S, Wollenhaupt J, Zerbini CA, Beaulieu AD, Schulze-Koops H, Durez P, Yao R, Vastesaeger N, Weng HH; GO-MORE Investigators. Combe B, et al. Ann Rheum Dis. 2014 Aug;73(8):1477-86. doi: 10.1136/annrheumdis-2013-203229. Epub 2013 Jun 5. Ann Rheum Dis. 2014. PMID: 23740226 Free PMC article. Clinical Trial.
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators. Smolen JS, et al. Lancet. 2009 Jul 18;374(9685):210-21. doi: 10.1016/S0140-6736(09)60506-7. Epub 2009 Jun 26. Lancet. 2009. PMID: 19560810 Clinical Trial.
Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice.
Álvaro-Gracia JM, Fernández-Nebro A, García-López A, Guzmán M, Blanco FJ, Navarro FJ, Bustabad S, Armendáriz Y, Román-Ivorra JA; ACT SURE. Álvaro-Gracia JM, et al. Reumatol Clin. 2014 Mar-Apr;10(2):94-100. doi: 10.1016/j.reuma.2013.07.002. Epub 2013 Oct 5. Reumatol Clin. 2014. PMID: 24099961 Free article. Clinical Trial. English, Spanish.
Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.
Notario Ferreira I, Ferrer González MA, Morales Garrido P, González Utrilla A, García Sanchez A, Soto Pino MJ, Suero Rosario E, Caro Hernández C, Añón Oñate I, Pérez Albaladejo L, Cáliz Cáliz R. Notario Ferreira I, et al. Reumatol Clin. 2017 Mar-Apr;13(2):78-84. doi: 10.1016/j.reuma.2016.03.014. Epub 2016 May 10. Reumatol Clin. 2017. PMID: 27174398 Free article. English, Spanish.
Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120.
Takeuchi T, Harigai M, Tanaka Y, Yamanaka H, Ishiguro N, Yamamoto K, Miyasaka N, Koike T, Ukyo Y, Ishii Y, Yoshinari T, Baker D; GO-MONO study group. Takeuchi T, et al. Mod Rheumatol. 2018 Sep;28(5):770-779. doi: 10.1080/14397595.2017.1404731. Epub 2017 Dec 8. Mod Rheumatol. 2018. PMID: 29219638 Clinical Trial.
Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial.
Tanaka Y, Harigai M, Takeuchi T, Yamanaka H, Ishiguro N, Yamamoto K, Miyasaka N, Koike T, Baker D, Ishii Y, Yoshinari T; GO-FORTH study group. Tanaka Y, et al. Mod Rheumatol. 2016 Jul;26(4):481-90. doi: 10.3109/14397595.2015.1109762. Epub 2015 Dec 23. Mod Rheumatol. 2016. PMID: 26474192 Free PMC article. Clinical Trial.
301 results